GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » Net Margin %

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Net Margin % : 27.70% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Zhejiang Garden Biopharmaceutical Co's Net Income for the three months ended in Mar. 2024 was ¥91 Mil. Zhejiang Garden Biopharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥330 Mil. Therefore, Zhejiang Garden Biopharmaceutical Co's net margin for the quarter that ended in Mar. 2024 was 27.70%.

The historical rank and industry rank for Zhejiang Garden Biopharmaceutical Co's Net Margin % or its related term are showing as below:

SZSE:300401' s Net Margin % Range Over the Past 10 Years
Min: 7.99   Med: 29.07   Max: 47.84
Current: 20.94


SZSE:300401's Net Margin % is ranked better than
90.08% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 3.255 vs SZSE:300401: 20.94

Zhejiang Garden Biopharmaceutical Co Net Margin % Historical Data

The historical data trend for Zhejiang Garden Biopharmaceutical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Garden Biopharmaceutical Co Net Margin % Chart

Zhejiang Garden Biopharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.84 39.92 43.31 27.07 17.57

Zhejiang Garden Biopharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.35 19.24 13.16 22.05 27.70

Competitive Comparison of Zhejiang Garden Biopharmaceutical Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Garden Biopharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Garden Biopharmaceutical Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Garden Biopharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Zhejiang Garden Biopharmaceutical Co's Net Margin % falls into.



Zhejiang Garden Biopharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Zhejiang Garden Biopharmaceutical Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=192.349/1094.652
=17.57 %

Zhejiang Garden Biopharmaceutical Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=91.483/330.273
=27.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Garden Biopharmaceutical Co  (SZSE:300401) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Zhejiang Garden Biopharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Zhejiang Garden Biopharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Business Description

Traded in Other Exchanges
N/A
Address
No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018
Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.
Executives
Shao Xu Jun Director
Liu Xiao Ping Executives
Shao Qin Xiang Director
Shao Jun Fang Director
Liu Jian Gang Directors, executives
Qian Guo Ping Executives
Zhu Jian Xing Supervisors
Yu Quan Heng Directors, executives, directors
Ma Huan Zheng Directors, executives
Li Hui Ying Supervisors
Ma Wen De Director
Chen Yi Executives
Gu Yi Kang Independent director

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Headlines

No Headlines